Blackstone and TPG Eye $17 Billion Hologic Acquisition
Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.
• Major Players: Private equity giants Blackstone (BX) and TPG are negotiating to buy Hologic (HOLX), a women's health-focused medical device company
• Deal Value: Transaction could exceed $17 billion including debt, with share price discussions above $75 per share
• Market Reaction: Hologic stock jumped 6% after-hours on the news, closing Friday at $69.85 with $15.5 billion market value
• Timeline: Announcement could come within days, though talks may still collapse before final agreement
• Company Focus: Hologic specializes in women's health diagnostics, including breast and cervical cancer screening plus Covid-19 testing solutions
• Deal Significance: Would rank among 2025's largest global private equity acquisitions if completed
• Previous Interest: Bloomberg reported last month that both firms had re-engaged with Hologic's board after earlier discussions